Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hirokazu Nakanishi"'
Autor:
Hirokazu Nakanishi, Tomoko Kobayashi, Shigeru Nakamura, Yuka Kobayashi, Hiroshi Okugawa, Ayumu Nozaki, Kazumasa Naruhashi, Nozomu Horiuchi
Publikováno v:
The American Journal of Emergency Medicine. 39:146-150
Bisono® is the world's first transdermal formulation of a bisoprolol, which is approved for the treatment of hypertension in Japan. We aimed to investigate the usefulness of this formulation in patients who were admitted to our hospital with cardiac
Autor:
Nozomu Horiuchi, Atsushi Funatsu, Masahiro Mizobuchi, Hirokazu Nakanishi, Hiroshi Okugawa, Yuka Kobayashi, Shigeru Nakamura, Tomoko Kobayashi, Ayumu Nozaki, Kazumasa Naruhashi
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 45:357-363
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 43:663-670
Autor:
Hirokazu Nakanishi, Yuka Kobayashi, Ayumu Nozaki, Eiji Shiwaku, Kazumasa Naruhashi, Satoshi Dote
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 43:273-278
Autor:
Hiroko Murakami, Tsuyoshi Fujii, Hirokazu Nakanishi, Satoshi Dote, Yuka Kobayashi, Ayumu Nozaki
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 41:93-97
Autor:
Takeshi Hattori, Hirokazu Nakanishi, Yuka Kobayashi, Satoshi Dote, Toshiko Shingu, Shoichi Doi, Maki Sawai, Ayumu Nozaki
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 39:395-405
Autor:
Tetsuro Urushidani, Yuusuke Sugihara, Ena Ochi, Hirokazu Nakanishi, Akiko Kamino, Nobuhito Shibata, Erina Kusabiraki, Kazumasa Naruhashi, Megumi Ueda
Publikováno v:
Clinical Pharmacology & Biopharmaceutics.
1.1. Introduction: The μ opioid receptor agonists, morphine and loperamide, are widely used orally and are suggested to be P-glycoprotein (P-gp) substrates. P-gp is expressed in the brain, intestine, and various tissues in human and rats. In the int
Autor:
Kazumasa Naruhashi, Erina Kusabiraki, Hirokazu Nakanishi, Akiko Kamino, Nobuhito Shibata, Shin-ichi Sugiura, Ena Ochi, Megumi Ueda
Publikováno v:
Clinical Pharmacology & Biopharmaceutics.
Introduction: Salazosulfapyridine (SASP) is an oral medication used to treat rheumatoid arthritis and inflammatory bowel disease, particularly ulcerative colitis. It has been reported that various transporters such as P-glycoprotein (Pgp) and multidr
Autor:
Maki Sawai, Ayumu Nozaki, Kazumasa Naruhashi, Hirokazu Nakanishi, Satoshi Dote, Yuka Kobayashi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences
Voriconazole concentrations display a large variability, which cannot completely be explained by known factors. We investigated the relationships of voriconazole concentration with patient-specific variables and concomitant medication to identify cli
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 36:343-346
Though antineoplastic agents are widely used in the treatment of cancer,genotoxic carcinogenic antineoplastic agents have mutagenicity and carcinogenicity risks for healthcare workers.Also,as it has been reported that higher concentrations of the ant